Latest filing published 06 Dec 2023 for Spago Nanomedical AB (publ), €8,844.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alan Raffensperger: trading record in brief
Alan Raffensperger discloses dealings in 2 companies, chiefly Spago Nanomedical AB (publ) and UBS. In total, 2 filings cover trades dated from 8 November 2023 to 5 December 2023.
Every open-market trade on record is a purchase: 2 purchases worth €13k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 6 December 2023 came the latest disclosure, an open-market purchase for €8,844 in Spago Nanomedical AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alan Raffensperger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 416,667 shares@ SEK 0.2443.3% of flowAktieISIN SE0004899474FI:csv-8930c12904a1091599f6Canonical exit: 4 Mar 2024 (T+90)
- 200,000 shares@ SEK 0.2617100.0% of flowAktieISIN SE0004899474FI:csv-c19eb10c27251d95fb02Canonical exit: 6 Feb 2024 (T+90)
2 of 2 declarations